personkort Teresa Lagergård, Institutionen för Biomedicin, avd Medicinsk mikrobiologi och immunologi

Basuppgifter

namn:
Teresa Lagergård
arbetsplats:
Institutionen för Biomedicin, avd Medicinsk mikrobiologi och immunologi
yrkestitel:
professor
e-post

Arbete

arbetsplats:
Institutionen för Biomedicin, avd Medicinsk mikrobiologi och immunologi
telefon:
031 7866220
arbetsgivarkategori:
Universitet/Högskola
adress:
Medicinaregatan 7A
postadress:
405 30 Göteborg
land:
Sverige

CV

Doctoral Thesis (1)

  1. Antibodies to Haemophilus influenzae and their bactericidal capacity.
    Dahlberg-Lagergård Teresa.
    Göteborgs: University of Gothenburg; 1982. ISBN 91-7222-497-5.
    [Source: User]

Article - Review (8)

  1. Prevention of invasive bacterial diseases by immunization with polysaccharide-protein conjugates.
    Robbins J B, Schneerson R, Szu S C, Fattom A, Yang Y, Lagergard T, Chu C, Sørensen U S.
    Curr Top Microbiol Immunol. 1989:146:169-80.
    [Links: PMID: 2659266][Source: PubMed®]
  2. Primum non nocere: a pharmacologically inert pertussis toxoid alone should be the next pertussis vaccine.
    Robbins J B, Pittman M, Trollfors B, Lagergard T A, Taranger J, Schneerson R.
    Pediatr Infect Dis J. 1993:12(10):795-807.
    [Links: PMID: 8284114][Source: PubMed®]
    Web of Science® citations 38
  3. Haemophilus ducreyi: pathogenesis and protective immunity.
    Lagergård T.
    Trends Microbiol. 1995:3(3):87-92.
    [Links: PMID: 7773593][Source: PubMed®]
  4. A toxoid vaccine for pertussis as well as diphtheria? Lessons to be relearned
    Schneerson R, Robbins J B, Taranger J, Lagergård T, Trollfors B.
    Lancet 1996:348(9037):1289-92.
    [Links: PMID: 8909384 | DOI länk][Source: PubMed®]
    Web of Science® citations 42
  5. Examination of similarities between diphtheria and pertussis and their toxoids provide insight into vaccine-induced protection to Bordetella pertussis.
    Schneerson R, Robbins J B, Taranger J, Lagerård T, Trollfors B.
    Dev Biol Stand. 1997:89:321-6.
    [Links: PMID: 9272366][Source: PubMed®]
    Web of Science® citations 2
  6. Standardization of acellular pertussis vaccine by assay of serum neutralizing antibodies to pertussis toxin (antitoxin): analogy with diphtheria toxoid.
    Robbins J B, Schneerson R, Trollfors B, Taranger J, Lagergård T.
    Dev Biol Stand. 1998:95:155-8.
    [Links: PMID: 9855426][Source: PubMed®]
  7. Immunity to pertussis. Not all virulence factors are protective antigens.
    Robbins J B, Schneerson R, Bryla D A, Trollfors B, Taranger J, Lagergård T.
    Adv Exp Med Biol. 1998:452:207-18.
    [Links: PMID: 9889975][Source: PubMed®]
    Web of Science® citations 2
  8. Immunologic and epidemiologic experience of vaccination with a monocomponent pertussis toxoid vaccine.
    Taranger J, Trollfors B, Bergfors E, Knutsson N, Lagergård T, Schneerson R, Robbins J B.
    Pediatrics 2001:108(6):E115.
    [Links: PMID: 11731642][Source: PubMed®]

Article - Peer reviewed scientific (130)

  1. [Bacteriology of infection foci in joints and bones].
    Lenartowicz T.
    Chir Narzadow Ruchu Ortop Pol 1973:38(6):711-5.
    [Links: PMID: 4770252][Source: PubMed®]
  2. Acute otitis media. A clinical bacteriological and serological study of children with frequent episodes of acute otitis media.
    Branefors-Helander P, Dahlberg T, Nylén O.
    Acta Otolaryngol. 1975:80(5-6):399-409.
    [Links: PMID: 885][Source: PubMed®]
  3. Study of antibody levels in children with purulent otitis media.
    Branefors P, Dahlberg T, Nylén O.
    Ann Otol Rhinol Laryngol Suppl 1980:89(3 Pt 2):117-20.
    [Links: PMID: 6778291][Source: PubMed®]
  4. Serum bactericidal effect on capsulated and non-capsulated Haemophilus influenzae.
    Branefors P, Dahlberg T.
    Acta Pathol Microbiol Scand C 1980:88(1):47-56.
    [Links: PMID: 6966461][Source: PubMed®]
  5. Characterization of the bactericidal antibody response against Haemophilus influenzae.
    Dahlberg T, Branefors P.
    Acta Pathol Microbiol Scand C 1980:88(3):115-20.
    [Links: PMID: 6969527][Source: PubMed®]
  6. Enzyme-linked immunosorbent assay for titration of Haemophilus influenzae capsular and O antigen antibodies.
    Dahlberg T, Branefors P.
    J Clin Microbiol. 1980:12(2):185-92.
    [Links: PMID: 7014605][Source: PubMed®]
  7. Meningitis and septicaemia due to haemophilus influenzae type b in pregnancy.
    Sandberg T, Dahlberg T.
    Br Med J (Clin Res Ed) 1981:282(6268):946.
    [Links: PMID: 6781662][Source: PubMed®]
  8. Quantitation of antibodies to Haemophilus influenzae type b in humans by enzyme-linked immunosorbent assay.
    Dahlberg T.
    J Clin Microbiol. 1981:13(6):1080-7.
    [Links: PMID: 7019237][Source: PubMed®]
  9. Target antigens for bactericidal and opsonizing antibodies to Haemophilus influenzae.
    Dahlberg-Lagergård T.
    Acta Pathol Microbiol Immunol Scand C 1982:90(4):209-16.
    [Links: PMID: 6982592][Source: PubMed®]
  10. Nature of cross-reactivity between Haemophilus influenzae types a and b and Streptococcus pneumoniae types 6A and 6B.
    Lagergård T, Branefors P.
    Acta Pathol Microbiol Immunol Scand C 1983:91(6):371-6.
    [Links: PMID: 6201038][Source: PubMed®]
  11. Bactericidal antibodies against noncapsular components of Haemophilus influenzae.
    Dahlberg-Lagergård T.
    J Clin Microbiol. 1983:17(3):428-31.
    [Links: PMID: 6601665][Source: PubMed®]
  12. Monoclonal antibodies against gastrointestinal tumour-associated antigens isolated as monosialogangliosides.
    Lindholm L, Holmgren J, Svennerholm L, Fredman P, Nilsson O, Persson B, Myrvold H, Lagergård T.
    Int Arch Allergy Appl Immunol. 1983:71(2):178-81.
    [Links: PMID: 6840874][Source: PubMed®]
  13. Incidence, predisposing factors and manifestations of invasive Haemophilus influenzae infections in adults.
    Trollfors B, Claesson B, Lagergård T, Sandberg T.
    Eur J Clin Microbiol. 1984:3(3):180-4.
    [Links: PMID: 6332016][Source: PubMed®]
  14. Incidence and prognosis of acute epiglottitis in children in a Swedish region.
    Claesson B, Trollfors B, Ekström-Jodal B, Jeppsson P H, Lagergård T, Nylén O, Rignér P.
    Pediatr Infect Dis 1984:3(6):534-8.
    [Links: PMID: 6334844][Source: PubMed®]
  15. Antibody responses to capsular polysaccharide, lipopolysaccharide, and outer membrane in adults infected with Haemophilus influenzae type b.
    Lagergård T, Nylén O, Sandberg T, Trollfors B.
    J Clin Microbiol. 1984:20(6):1154-8.
    [Links: PMID: 6335151][Source: PubMed®]
  16. Detection by monoclonal antibody of carbohydrate antigen CA 50 in serum of patients with carcinoma.
    Holmgren J, Lindholm L, Persson B, Lagergård T, Nilsson O, Svennerholm L, Rudenstam C M, Unsgaard B, Yngvason F, Pettersson S.
    Br Med J (Clin Res Ed) 1984:288(6429):1479-82.
    [Links: PMID: 6426610][Source: PubMed®]
  17. Method for testing adherence of Haemophilus influenzae to human buccal epithelial cells.
    Porras O, Svanborg-Edén C, Lagergård T, Hanson L A.
    Eur J Clin Microbiol. 1985:4(3):310-5.
    [Links: PMID: 3874775][Source: PubMed®]
  18. Etiology of community-acquired pneumonia in patients requiring hospitalization.
    Berntsson E, Blomberg J, Lagergård T, Trollfors B.
    Eur J Clin Microbiol. 1985:4(3):268-72.
    [Links: PMID: 4018066][Source: PubMed®]
  19. An enzyme-linked immunosorbent method for detection of antibodies to pertussis toxin.
    Zackrisson G, Lönnroth I, Lagergård Teresa.
    Acta Pathol Immunol Scand, Sect C 1986:94:227-231.
    [Source: User]
  20. Etiology of community-acquired pneumonia in out-patients.
    Berntsson E, Lagergård T, Strannegård O, Trollfors B.
    Eur J Clin Microbiol. 1986:5(4):446-7.
    [Links: PMID: 3093224][Source: PubMed®]
  21. Antibody levels to pertussis toxin in preschool children in a non-vaccinating country (Sweden).
    Zackrisson G, Lagergård T, Taranger J, Trollfors B.
    Ann Sclavo Collana Monogr 1986:3(1-2):347-50.
    [Links: PMID: 3426879][Source: PubMed®]
  22. Inhibition of attachment of Streptococcus pneumoniae and Haemophilus influenzae by human milk and receptor oligosaccharides.
    Andersson B, Porras O, Hanson L A, Lagergård T, Svanborg-Edén C.
    J Infect Dis. 1986:153(2):232-7.
    [Links: PMID: 3484772][Source: PubMed®]
  23. Difference in structure between type b and nontypable Haemophilus influenzae populations.
    Porras O, Caugant D A, Gray B, Lagergård T, Levin B R, Svanborg-Edén C.
    Infect Immun. 1986:53(1):79-89.
    [Links: PMID: 3487508][Source: PubMed®]
  24. Application of multilocus enzyme gel electrophoresis to Haemophilus influenzae.
    Porras O, Caugant D A, Lagergård T, Svanborg-Edén C.
    Infect Immun. 1986:53(1):71-8.
    [Links: PMID: 3522433][Source: PubMed®]
  25. Serum antibody response to capsular polysaccharide, outer membrane, and lipooligosaccharide in children with invasive Haemophilus influenzae type b infections.
    Claesson B A, Lagergård T, Trollfors B, Gothefors L, Jodal U.
    J Clin Microbiol. 1987:25(12):2339-43.
    [Links: PMID: 3501433][Source: PubMed®]
  26. Antibody response to pertussis toxin in patients with clinical pertussis measured by enzyme-linked immunosorbent assay.
    Zackrisson G, Krantz I, Lagergård T, Larsson P, Sekura R, Sigurs N, Taranger J, Trollfors B.
    Eur J Clin Microbiol Infect Dis. 1988:7(2):149-54.
    [Links: PMID: 2899027][Source: PubMed®]
  27. Mortality and morbidity from invasive bacterial infections during a clinical trial of acellular pertussis vaccines in Sweden.
    Storsaeter J, Olin P, Renemar B, Lagergård T, Norberg R, Romanus V, Tiru M.
    Pediatr Infect Dis J. 1988:7(9):637-45.
    [Links: PMID: 3050858][Source: PubMed®]
  28. Serum antibody response to filamentous hemagglutinin in patients with clinical pertussis measured by an enzyme-linked immunosorbent assay.
    Zackrisson G, Arminjon F, Krantz I, Lagergård T, Sigurs N, Taranger J, Trollfors B.
    Eur J Clin Microbiol Infect Dis. 1988:7(6):764-70.
    [Links: PMID: 3145859][Source: PubMed®]
  29. Comparison between radioimmunoassay and direct and indirect enzyme-linked immunosorbent assays for determination of antibodies against Haemophilus influenzae type b capsular polysaccharide.
    Lagergård T, Trollfors B, Claesson B A, Schneerson R, Robbins J B.
    J Clin Microbiol. 1988:26(12):2554-7.
    [Links: PMID: 3230133][Source: PubMed®]
  30. Development of serum antibodies of the immunoglobulin G class and subclasses against the capsular polysaccharide of Haemophilus influenzae type b in children and adults with invasive infections.
    Claesson B A, Lagergård T, Trollfors B.
    J Clin Microbiol. 1988:26(12):2549-53.
    [Links: PMID: 3265942][Source: PubMed®]
  31. Clinical and immunologic responses to the capsular polysaccharide of Haemophilus influenzae type b alone or conjugated to tetanus toxoid in 18- to 23-month-old children.
    Claesson B A, Trollfors B, Lagergard T, Taranger J, Bryla D, Otterman G, Cramton T, Yang Y, Reimer C B, Robbins J B.
    J Pediatr. 1988:112(5):695-702.
    [Links: PMID: 3361379][Source: PubMed®]
  32. Etiology of community-acquired pneumonia in children based on antibody responses to bacterial and viral antigens.
    Claesson B A, Trollfors B, Brolin I, Granström M, Henrichsen J, Jodal U, Juto P, Kallings I, Kanclerski K, Lagergård T.
    Pediatr Infect Dis J. 1989:8(12):856-62.
    [Links: PMID: 2516622][Source: PubMed®]
  33. Subclass compositions of immunoglobulin G to pertussis toxin in patients with whooping cough, in healthy individuals, and in recipients of a pertussis toxoid vaccine.
    Zackrisson G, Lagergård T, Trollfors B.
    J Clin Microbiol. 1989:27(7):1567-71.
    [Links: PMID: 2768444][Source: PubMed®]
  34. Protective levels of serum antibodies stimulated in infants by two injections of Haemophilus influenzae type b capsular polysaccharide-tetanus toxoid conjugate.
    Claesson B A, Schneerson R, Robbins J B, Johansson J, Lagergard T, Taranger J, Bryla D, Levi L, Cramton T, Trollfors B.
    J Pediatr. 1989:114(1):97-100.
    [Links: PMID: 2783345][Source: PubMed®]
  35. Rapid diagnosis of pertussis.
    Confer D L, Zackrisson G, Lagergård T, Eaton J W.
    Scand J Infect Dis. 1990:22(2):175-7.
    [Links: PMID: 2162557][Source: PubMed®]
    Web of Science® citations 5
  36. Immunogenicity and safety of a pertussis vaccine composed of pertussis toxin inactivated by hydrogen peroxide, in 18- to 23-month-old children.
    Krantz I, Sekura R, Trollfors B, Taranger J, Zackrisson G, Lagergård T, Schneerson R, Robbins J.
    J Pediatr. 1990:116(4):539-43.
    [Links: PMID: 2319400][Source: PubMed®]
    Web of Science® citations 15
  37. Duration of serum antibodies elicited by Haemophilus influenzae type b capsular polysaccharide alone or conjugated to tetanus toxoid in 18- to 23-month-old children.
    Claesson B A, Schneerson R, Trollfors B, Lagergård T, Taranger J, Robbins J B.
    J Pediatr. 1990:116(6):929-31.
    [Links: PMID: 2348298][Source: PubMed®]
    Web of Science® citations 19
  38. Immunoglobulin A antibodies to pertussis toxin and filamentous hemagglutinin in saliva from patients with pertussis.
    Zackrisson G, Lagergård T, Trollfors B, Krantz I.
    J Clin Microbiol. 1990:28(7):1502-5.
    [Links: PMID: 2380376][Source: PubMed®]
    Web of Science® citations 11
  39. Synthesis and immunological properties of conjugates composed of group B streptococcus type III capsular polysaccharide covalently bound to tetanus toxoid.
    Lagergard T, Shiloach J, Robbins J B, Schneerson R.
    Infect Immun. 1990:58(3):687-94.
    [Links: PMID: 2407652][Source: PubMed®]
    Web of Science® citations 62
  40. Persistence of serum antibodies elicited by Haemophilus influenzae type b-tetanus toxoid conjugate vaccine in infants vaccinated at 3, 5 and 12 months of age.
    Claesson B A, Schneerson R, Lagergård T, Trollfors B, Taranger J, Johansson J, Bryla D, Robbins J B.
    Pediatr Infect Dis J. 1991:10(8):560-4.
    [Links: PMID: 1891286][Source: PubMed®]
    Web of Science® citations 27
  41. Diagnosis of pneumonia by cultures, bacterial and viral antigen detection tests, and serology with special reference to antibodies against pneumococcal antigens.
    Burman L A, Trollfors B, Andersson B, Henrichsen J, Juto P, Kallings I, Lagergård T, Möllby R, Norrby R.
    J Infect Dis. 1991:163(5):1087-93.
    [Links: PMID: 2019757][Source: PubMed®]
    Web of Science® citations 74
  42. Antibody response to outer membrane of noncapsulated Haemophilus influenzae isolated from the nasopharynx of children with pneumonia.
    Claesson B A, Lagergård T, Trollfors B.
    Pediatr Infect Dis J. 1991:10(2):104-8.
    [Links: PMID: 2062599][Source: PubMed®]
    Web of Science® citations 9
  43. Comparison of Neutralizing antibodies (antitoxin) and IgG, IgM and IgA antibodies in infants after vaccination against Diphtheria.
    Lagergård Teresa, Trollfors B, Claesson BA, Karlberg J, Taranger J.
    Eur J Clin Microb and Inf Dis 1992:11:341-45.
    [Source: User]
    Web of Science® citations 12
  44. The role of Haemophilus ducreyi bacteria, cytotoxin, endotoxin and antibodies in animal models for study of chancroid.
    Lagergård T.
    Microb Pathog. 1992:13(3):203-17.
    [Links: PMID: 1291843][Source: PubMed®]
    Web of Science® citations 43
  45. The role of Haemophilus ducreyi bacteria, cytotoxin, endotoxin and antibodies in animal models for study of chancroid.
    Lagergård T.
    Microb Pathog. 1992:13(3):203-17.
    [Links: PMID: 1291843][Source: PubMed®]
    Web of Science® citations 43
  46. Characterization of the serum antibody response to the capsular polysaccharide of Haemophilus influenzae type b in children with invasive infections.
    Trollfors B, Lagergård T, Claesson B A, Thornberg E, Martinell J, Schneerson R.
    J Infect Dis. 1992:166(6):1335-9.
    [Links: PMID: 1431250][Source: PubMed®]
    Web of Science® citations 20
  47. Synthesis of a conjugate vaccine composed of pneumococcus type 14 capsular polysaccharide bound to pertussis toxin.
    Schneerson R, Levi L, Robbins J B, Bryla D M, Schiffman G, Lagergard T.
    Infect Immun. 1992:60(9):3528-32.
    [Links: PMID: 1500160][Source: PubMed®]
    Web of Science® citations 28
  48. Isotype composition of antibodies to streptococcus group B type III polysaccharide and to tetanus toxoid in maternal, cord blood sera and in breast milk.
    Lagergård T, Thiringer K, Wassén L, Schneerson R, Trollfors B.
    Eur J Pediatr. 1992:151(2):98-102.
    [Links: PMID: 1537371][Source: PubMed®]
    Web of Science® citations 11
  49. Haemophilus ducreyi, a cytotoxin-producing bacterium.
    Purvén M, Lagergård T.
    Infect Immun. 1992:60(3):1156-62.
    [Links: PMID: 1541531][Source: PubMed®]
    Web of Science® citations 71
  50. Haemophilus ducreyi, a cytotoxin-producing bacterium.
    Purvén M, Lagergård T.
    Infect Immun. 1992:60(3):1156-62.
    [Links: PMID: 1541531][Source: PubMed®]
    Web of Science® citations 71
  51. Serum antibody responses to nonencapsulated Haemophilus influenzae isolated from the nasopharynx of children with pneumonia.
    Claesson B A, Lagergård T, Trollfors B.
    J Infect Dis. 1992:165:S205-6.
    [Links: PMID: 1588168][Source: PubMed®]
    Web of Science® citations 1
  52. Serum antibodies against a 69-kilodalton outer-membrane protein, pertactin, from Bordetella pertussis in nonvaccinated children with and without a history of clinical pertussis.
    Trollfors B, Zackrisson G, Taranger J, Lagergård T.
    J Pediatr. 1992:120(6):924-6.
    [Links: PMID: 1593352][Source: PubMed®]
    Web of Science® citations 8
  53. Evidence of Haemophilus ducreyi adherence to and cytotoxin destruction of human epithelial cells.
    Lagergård T, Purvén M, Frisk A.
    Microb Pathog. 1993:14(6):417-31.
    [Links: PMID: 8412616 | DOI länk][Source: PubMed®]
    Web of Science® citations 37
  54. Neutralizing antibodies to Haemophilus ducreyi cytotoxin.
    Lagergård T, Purvén M.
    Infect Immun. 1993:61(4):1589-92.
    [Links: PMID: 8454369][Source: PubMed®]
    Web of Science® citations 22
  55. How common is whooping cough in a nonvaccinating country?
    Isacson J, Trollfors B, Taranger J, Zackrisson G, Lagergård T.
    Pediatr Infect Dis J. 1993:12(4):284-8.
    [Links: PMID: 8483621][Source: PubMed®]
    Web of Science® citations 30
  56. Safety, immunogenicity and an open, retrospective study of efficacy of a monocomponent pertussis toxoid vaccine in infants.
    Isacson J, Trollfors B, Taranger J, MacDowall I, Johansson J, Lagergård T, Robbins J B.
    Pediatr Infect Dis J. 1994:13(1):22-7.
    [Links: PMID: 8170728][Source: PubMed®]
    Web of Science® citations 15
  57. Antibodies against Haemophilus influenzae type b and tetanus in infants after subcutaneous vaccination with PRP-T/diphtheria, or PRP-OMP/diphtheria-tetanus vaccines.
    Carlsson R M, Claesson B A, Iwarson S, Lagergård T, Käyhty H.
    Pediatr Infect Dis J. 1994:13(1):27-33.
    [Links: PMID: 8170729][Source: PubMed®]
    Web of Science® citations 12
  58. Monoclonal antibodies against Haemophilus ducreyi lipopolysaccharide and their diagnostic applicability.
    Ahmed H, Borelli S, Jonasson J, Eriksson L, Hanson S, Höjer B, Lagergård Teresa, Sunkuntu M, Musaba E, Roggen E, Lindberg A.A.
    Eur J Clin Microb Inf Dis 1995:14:892-898.
    [Source: User]
    Web of Science® citations 16
  59. Cytotoxin production in 100 strains of Haemophilus ducreyi from different geographic locations.
    Purvén M, Falsen E, Lagergård T.
    FEMS Microbiol Lett. 1995:129(2-3):221-4.
    [Links: PMID: 7607403][Source: PubMed®]
    Web of Science® citations 18
  60. Localisation and immunological properties of a 24-kDa surface protein of Haemophilus ducreyi.
    Frisk A, Roggen E L, Lagergård T.
    J Med Microbiol. 1995:43(3):192-200.
    [Links: PMID: 7650727][Source: PubMed®]
    Web of Science® citations 7
  61. Acquisition of IgG serum antibodies against two Bordetella antigens (filamentous hemagglutinin and pertactin) in children with no symptoms of pertussis.
    Isacson J, Trollfors B, Taranger J, Lagergård T.
    Pediatr Infect Dis J. 1995:14(6):517-21.
    [Links: PMID: 7667057][Source: PubMed®]
    Web of Science® citations 25
  62. A placebo-controlled trial of a pertussis-toxoid vaccine.
    Trollfors B, Taranger J, Lagergård T, Lind L, Sundh V, Zackrisson G, Lowe C U, Blackwelder W, Robbins J B.
    N Engl J Med. 1995:333(16):1045-50.
    [Links: PMID: 7675047][Source: PubMed®]
    Web of Science® citations 190
  63. Serum bactericidal activity and phagocytosis in host defence against Haemophilus ducreyi.
    Lagergård T, Frisk A, Purvèn M, Nilsson L A.
    Microb Pathog. 1995:18(1):37-51.
    [Links: PMID: 7783597][Source: PubMed®]
    Web of Science® citations 19
  64. Serum antibodies to the components of diphtheria-tetanus-pertussis vaccine in Polish children related to vaccination status.
    Torbicka E, Lagergård T, Trollfors B.
    Infection 1995:23(4):212-5.
    [Links: PMID: 8522378][Source: PubMed®]
    Web of Science® citations 0
  65. Response and decline of serum IgG antibodies to pertussis toxin, filamentous hemagglutinin and pertactin in children with pertussis.
    Isacson J, Trollfors B, Hedvall G, Taranger J, Zackrisson G.
    Scand J Infect Dis. 1995:27(3):273-7.
    [Links: PMID: 8539553][Source: PubMed®]
    Web of Science® citations 20
  66. Serum antibodies against haemophilus influenzae type b and tetanus at 2.5 years of age: a follow-up of 2 different regimens of infant vaccination.
    Carlsson R M, Claesson B A, Lagergård T, Käyhty H.
    Scand J Infect Dis. 1996:28(5):519-23.
    [Links: PMID: 8953685][Source: PubMed®]
    Web of Science® citations 9
  67. Comparison of the Etest with agar dilution for antimicrobial susceptibility testing of Haemophilus ducreyi.
    Lagergård T, Frisk A, Trollfors B.
    J Antimicrob Chemother. 1996:38(5):849-52.
    [Links: PMID: 8961054][Source: PubMed®]
    Web of Science® citations 2
  68. Comparison of a toxin neutralization assay and ELISA for determination of pertussis toxin antibodies.
    Isacson Jerker, Trollfors Birger, Lagergård Teresa, Taranger John.
    Serodiagnosis and Immunotherapy in Infectious Diseases 1997:8:163-7.
    [Source: User]
  69. Unchanged efficacy of a pertussis toxoid vaccine throughout the two years after the third vaccination of infants.
    Taranger J, Trollfors B, Lagergård T, Lind L, Sundh V, Zackrisson G, Bryla D A, Robbins J B.
    Pediatr Infect Dis J. 1997:16(2):180-4.
    [Links: PMID: 9041597][Source: PubMed®]
    Web of Science® citations 27
  70. A diffusible cytotoxin of Haemophilus ducreyi.
    Cope L D, Lumbley S, Latimer J L, Klesney-Tait J, Stevens M K, Johnson L S, Purven M, Munson R S, Lagergard T, Radolf J D, Hansen E J.
    Proc Natl Acad Sci U.S.A. 1997:94(8):4056-61.
    [Links: PMID: 9108104][Source: PubMed®]
    Web of Science® citations 156
  71. Efficacy of a monocomponent pertussis toxoid vaccine after household exposure to pertussis.
    Trollfors B, Taranger J, Lagergård T, Lind L, Sundh V, Zackrisson G, Bryla D A, Robbins J B.
    J Pediatr. 1997:130(4):532-6.
    [Links: PMID: 9108848][Source: PubMed®]
    Web of Science® citations 17
  72. Anticarrier immunity suppresses the antibody response to polysaccharide antigens after intranasal immunization with the polysaccharide-protein conjugate.
    Bergquist C, Lagergård T, Holmgren J.
    Infect Immun. 1997:65(5):1579-83.
    [Links: PMID: 9125533][Source: PubMed®]
    Web of Science® citations 26
  73. Intranasal vaccination of humans with recombinant cholera toxin B subunit induces systemic and local antibody responses in the upper respiratory tract and the vagina.
    Bergquist C, Johansson E L, Lagergård T, Holmgren J, Rudin A.
    Infect Immun. 1997:65(7):2676-84.
    [Links: PMID: 9199436][Source: PubMed®]
    Web of Science® citations 160
  74. Structurally defined epitopes of Haemophilus ducreyi lipooligosaccharides recognized by monoclonal antibodies.
    Ahmed H J, Frisk A, Månsson J E, Schweda E K, Lagergård T.
    Infect Immun. 1997:65(8):3151-8.
    [Links: PMID: 9234768][Source: PubMed®]
    Web of Science® citations 14
  75. Purification and identification of Haemophilus ducreyi cytotoxin by use of a neutralizing monoclonal antibody.
    Purvén M, Frisk A, Lönnroth I, Lagergard T.
    Infect Immun. 1997:65(8):3496-9.
    [Links: PMID: 9234821][Source: PubMed®]
    Web of Science® citations 30
  76. Prevalence of antibodies against group B streptococcal capsular polysaccharides in healthy Chinese neonates.
    Shen X, Yang Y, Zhang J, Berg S, Lagergård T, Trollfors B.
    Pediatr Infect Dis J. 1997:16(12):1179-80.
    [Links: PMID: 9427467][Source: PubMed®]
    Web of Science® citations 0
  77. GroEL heat shock protein of Haemophilus ducreyi: association with cell surface and capacity to bind to eukaryotic cells.
    Frisk A, Ison C A, Lagergård T.
    Infect Immun. 1998:66(3):1252-7.
    [Links: PMID: 9488422][Source: PubMed®]
    Web of Science® citations 67
  78. Evaluation of PCR for diagnosis of Bordetella pertussis and Bordetella parapertussis infections.
    Lind-Brandberg L, Welinder-Olsson C, Lagergård T, Taranger J, Trollfors B, Zackrisson G.
    J Clin Microbiol. 1998:36(3):679-83.
    [Links: PMID: 9508295][Source: PubMed®]
    Web of Science® citations 45
  79. Immunization of children with pertussis toxoid decreases spread of pertussis within the family.
    Trollfors B, Taranger J, Lagergård T, Sundh V, Bryla D A, Schneerson R, Robbins J B.
    Pediatr Infect Dis J. 1998:17(3):196-9.
    [Links: PMID: 9535245][Source: PubMed®]
    Web of Science® citations 18
  80. Antibodies to group B streptococci in neonates and infants.
    Berg S, Kasvi S, Trollfors B, Pilichowska-Paszkiet J, Fattom A, Tessin I, Lagergård T.
    Eur J Pediatr. 1998:157(3):221-4.
    [Links: PMID: 9537489][Source: PubMed®]
    Web of Science® citations 3
  81. Aetiology of acute epiglottitis in adults.
    Trollfors B, Nylén O, Carenfelt C, Foglé-Hansson M, Freijd A, Geterud A, Hugosson S, Prellner K, Neovius E, Nordell H, Bäckman A, Kaijser B, Lagergård T, Leinonen M, Olcén P, Pilichowska-Paszkiet J.
    Scand J Infect Dis. 1998:30(1):49-51.
    [Links: PMID: 9670359][Source: PubMed®]
    Web of Science® citations 18
  82. Characterization of mechanisms involved in adherence of Haemophilus ducreyi to eukaryotic cells.
    Frisk A, Lagergård T.
    APMIS 1998:106(5):539-46.
    [Links: PMID: 9674891][Source: PubMed®]
    Web of Science® citations 7
  83. Antibodies specific to surface antigens are not effective in complement-mediated killing of Haemophilus ducreyi.
    Frisk A, Ahmed H J, Van Dyck E, Lagergård T.
    Microb Pathog. 1998:25(2):67-75.
    [Links: PMID: 9712686 | DOI länk][Source: PubMed®]
    Web of Science® citations 10
  84. Antibody responses in serum and lung to intranasal immunization with Haemophilus influenzae type b polysaccharide conjugated to cholera toxin B subunit and tetanus toxoid.
    Bergquist C, Lagergård T, Holmgren J.
    APMIS 1998:106(8):800-6.
    [Links: PMID: 9744766][Source: PubMed®]
    Web of Science® citations 12
  85. Acquisition of serum antibodies against filamentous hemagglutinin and pertactin unrelated to Bordetells pertussis infection.
    Carlsson R-M, Claesson B, Lagergård T, Trollfors B.
    Clin Microbiol Infect 1999:5:709-712.
    [Source: User]
  86. Serum IgG antibody responses to pertussis toxin and filamentous hemagglutinin in nonvaccinated and vaccinated children and adults with pertussis.
    Trollfors B, Taranger J, Lagergård T, Sundh V, Bryla D A, Schneerson R, Robbins J B.
    Clin Infect Dis. 1999:28(3):552-9.
    [Links: PMID: 10194077 | DOI länk][Source: PubMed®]
    Web of Science® citations 10
  87. Characterization of a Haemophilus ducreyi mutant deficient in expression of cytolethal distending toxin.
    Stevens M K, Latimer J L, Lumbley S R, Ward C K, Cope L D, Lagergard T, Hansen E J.
    Infect Immun. 1999:67(8):3900-8.
    [Links: PMID: 10417154][Source: PubMed®]
    Web of Science® citations 44
  88. Parapertussis and pertussis: differences and similarities in incidence, clinical course, and antibody responses.
    Bergfors E, Trollfors B, Taranger J, Lagergård T, Sundh V, Zackrisson G.
    Int J Infect Dis. 1999:3(3):140-6.
    [Links: PMID: 10460925][Source: PubMed®]
  89. Vaccination of infants with a four-dose and a three-dose vaccination schedule.
    Taranger J, Trollfors B, Knutsson N, Sundh V, Lagergård T, Ostergaard E.
    Vaccine 1999:18(9-10):884-91.
    [Links: PMID: 10580202][Source: PubMed®]
    Web of Science® citations 13
  90. The cytolethal distending toxin from the chancroid bacterium Haemophilus ducreyi induces cell-cycle arrest in the G2 phase.
    Cortes-Bratti X, Chaves-Olarte E, Lagergård T, Thelestam M.
    J Clin Invest. 1999:103(1):107-15.
    [Links: PMID: 9884340 | DOI länk][Source: PubMed®]
    Web of Science® citations 84
  91. Correlation between pertussis toxin IgG antibodies in postvaccination sera and subsequent protection against pertussis.
    Taranger J, Trollfors B, Lagergård T, Sundh V, Bryla D A, Schneerson R, Robbins J B.
    J Infect Dis. 2000:181(3):1010-3.
    [Links: PMID: 10720524 | DOI länk][Source: PubMed®]
    Web of Science® citations 46
  92. Systemic and mucosal immune responses in mice after mucosal immunization with group B streptococcus type III capsular polysaccharide-cholera toxin B subunit conjugate vaccine.
    Shen X, Lagergård T, Yang Y, Lindblad M, Fredriksson M, Holmgren J.
    Infect Immun. 2000:68(10):5749-55.
    [Links: PMID: 10992481][Source: PubMed®]
    Web of Science® citations 34
  93. Cellular internalization of cytolethal distending toxin from Haemophilus ducreyi.
    Cortes-Bratti X, Chaves-Olarte E, Lagergård T, Thelestam M.
    Infect Immun. 2000:68(12):6903-11.
    [Links: PMID: 11083812][Source: PubMed®]
    Web of Science® citations 51
  94. Preparation and preclinical evaluation of experimental group B streptococcus type III polysaccharide-cholera toxin B subunit conjugate vaccine for intranasal immunization.
    Shen X, Lagergård T, Yang Y, Lindblad M, Fredriksson M, Holmgren J.
    Vaccine 2000:19(7-8):850-61.
    [Links: PMID: 11115709][Source: PubMed®]
    Web of Science® citations 16
  95. Serotypes and clinical manifestations of group B streptococcal infections in western Sweden.
    Berg S, Trollfors B, Lagergård T, Zackrisson G, Claesson B A.
    Clin Microbiol Infect. 2000:6(1):9-13.
    [Links: PMID: 11168030][Source: PubMed®]
    Web of Science® citations 28
  96. The Haemophilus ducreyi cytolethal distending toxin induces cell cycle arrest and apoptosis via the DNA damage checkpoint pathways.
    Cortes-Bratti X, Karlsson C, Lagergård T, Thelestam M, Frisan T.
    J Biol Chem. 2001:276(7):5296-302.
    [Links: PMID: 11076947 | DOI länk][Source: PubMed®]
    Web of Science® citations 73
  97. Group B Streptococcus capsular polysaccharide-cholera toxin B subunit conjugate vaccines prepared by different methods for intranasal immunization.
    Shen X, Lagergård T, Yang Y, Lindblad M, Fredriksson M, Holmgren J.
    Infect Immun. 2001:69(1):297-306.
    [Links: PMID: 11119518 | DOI länk][Source: PubMed®]
    Web of Science® citations 8
  98. The impact of Haemophilus ducreyi cytolethal distending toxin on cells involved in immune response.
    Svensson L A, Tarkowski A, Thelestam M, Lagergård T.
    Microb Pathog. 2001:30(3):157-66.
    [Links: PMID: 11273741 | DOI länk][Source: PubMed®]
    Web of Science® citations 22
  99. Effect of pre-existing immunity for systemic and mucosal immune responses to intranasal immunization with group B Streptococcus type III capsular polysaccharide-cholera toxin B subunit conjugate.
    Shen X, Lagergård T, Yang Y, Lindblad M, Fredriksson M, Wallerström G, Holmgren J.
    Vaccine 2001:19(25-26):3360-8.
    [Links: PMID: 11348699][Source: PubMed®]
    Web of Science® citations 12
  100. The role of different protein components from the Haemophilus ducreyi cytolethal distending toxin in the generation of cell toxicity.
    Frisk A, Lebens M, Johansson C, Ahmed H, Svensson L, Ahlman K, Lagergård T.
    Microb Pathog. 2001:30(6):313-24.
    [Links: PMID: 11399138 | DOI länk][Source: PubMed®]
    Web of Science® citations 49
  101. Immunogenicity and reactogenicity of diphtheria, tetanus and pertussis toxoids combined with inactivated polio vaccine, when administered concomitantly with or as a diluent for a Hib conjugate vaccine.
    Knutsson N, Trollfors B, Taranger J, Bergfors E, Sundh V, Lagergård T, Ostergaard E, Cicirello H, Käyhty H.
    Vaccine 2001:19(31):4396-403.
    [Links: PMID: 11483264][Source: PubMed®]
    Web of Science® citations 8
  102. Serum immunoglobulin G antibody responses to Bordetella pertussis lipooligosaccharide and B. parapertussis lipopolysaccharide in children with pertussis and parapertussis.
    Trollfors B, Lagergård T, Taranger J, Bergfors E, Schneerson R, Robbins J B.
    Clin Diagn Lab Immunol. 2001:8(5):1015-7.
    [Links: PMID: 11527820 | DOI länk][Source: PubMed®]
    Web of Science® citations 5
  103. Mass vaccination of children with pertussis toxoid--decreased incidence in both vaccinated and nonvaccinated persons.
    Taranger J, Trollfors B, Lagergård Teresa, Knutsson N, Sundh V, Lagergård T, Lind-Brandberg L, Zackrisson G, White J, Cicirello H, Fusco J, Robbins J B.
    Clin Infect Dis. 2001:33(7):1004-10.
    [Links: PMID: 11528572 | DOI länk][Source: PubMed®]
    Web of Science® citations 46
  104. Prevalence of cdtABC genes encoding cytolethal distending toxin among Haemophilus ducreyi and Actinobacillus actinomycetemcomitans strains.
    Ahmed H J, Svensson L A, Cope L D, Latimer J L, Hansen E J, Ahlman K, Bayat-Turk J, Klamer D, Lagergård T.
    J Med Microbiol. 2001:50(10):860-4.
    [Links: PMID: 11599734][Source: PubMed®]
    Web of Science® citations 28
  105. In vitro and in vivo interactions of Haemophilus ducreyi with host phagocytes.
    Ahmed Hinda J, Johansson Catharina, Svensson Liselott A, Ahlman Karin, Verdrengh Margareta, Lagergård Teresa.
    Infect Immun. 2002:70(2):899-908.
    [Links: PMID: 11796625][Source: PubMed®]
    Web of Science® citations 17
  106. The cytolethal distending toxin of Haemophilus ducreyi inhibits endothelial cell proliferation.
    Svensson Liselott A, Henning Petra, Lagergård Teresa.
    Infect Immun. 2002:70(5):2665-9.
    [Links: PMID: 11953409][Source: PubMed®]
    Web of Science® citations 10
  107. Toxicity and immunogenicity of purified Haemophilus ducreyi cytolethal distending toxin in a rabbit model.
    Wising Catharina, Svensson Liselott A, Ahmed Hinda J, Sundaeus Vivianne, Ahlman Karin, Jonsson Ing-Marie, Mölne Lena, Lagergård Teresa.
    Microb Pathog. 2002:33(2):49-62.
    [Links: PMID: 12202104][Source: PubMed®]
    Web of Science® citations 27
  108. Etiology of genital ulcer disease and association with human immunodeficiency virus infection in two tanzanian cities.
    Ahmed Hinda J, Mbwana Judica, Gunnarsson Eva, Ahlman Karin, Guerino Chalamilla, Svensson Liselott A, Mhalu Fred, Lagergard Teresa.
    Sexually transmitted diseases 2003:30(2):114-9.
    [Links: PMID: 12567167][Source: PubMed®]
    Web of Science® citations 29
  109. Determination of pertactin IgG antibodies for the diagnosis of pertussis.
    Trollfors B, Lagergård T, Gunnarsson E, Taranger J.
    Clin Microbiol Infect. 2003:9(7):585-9.
    [Links: PMID: 12925096][Source: PubMed®]
    Web of Science® citations 4
  110. Specificity of antibodies directed against the cytolethal distending toxin of Haemophilus ducreyi in patients with chancroid.
    Mbwana Judica, Ahmed Hinda J, Ahlman Karin, Sundaeus Vivian, Dahlén Gunnar, Lyamuya Eligius, Lagergård Teresa.
    Microb Pathog. 2003:35(3):133-7.
    [Links: PMID: 12927521][Source: PubMed®]
    Web of Science® citations 9
  111. Interactions of Haemophilus ducreyi and purified cytolethal distending toxin with human monocyte-derived dendritic cells, macrophages and CD4+ T cells.
    Xu Tingting, Lundqvist Annika, Ahmed Hinda J, Eriksson Kristina, Yang Yonghong, Lagergård Teresa.
    Microbes Infect. 2004:6(13):1171-81.
    [Links: PMID: 15488736 | DOI länk][Source: PubMed®]
    Web of Science® citations 20
  112. Reduced immunogenicity of diphtheria and tetanus toxoids when combined with pertussis toxoid.
    Trollfors Birger, Taranger John, Lagergård Teresa, Sundh Valter.
    Pediatr Infect Dis J. 2005:24(1):85-6.
    [Links: PMID: 15665717][Source: PubMed®]
    Web of Science® citations 7
  113. Induction of apoptosis/necrosis in various human cell lineages by Haemophilus ducreyi cytolethal distending toxin.
    Wising Catharina, Azem Jozef, Zetterberg Madeleine, Svensson Liselott A, Ahlman Karin, Lagergård Teresa.
    Toxicon 2005:45(6):767-76.
    [Links: PMID: 15804526 | DOI länk][Source: PubMed®]
    Web of Science® citations 16
  114. Cytokine responses of human gingival fibroblasts to Actinobacillus actinomycetemcomitans cytolethal distending toxin.
    Belibasakis G N, Johansson A, Wang Y, Chen C, Lagergård T, Kalfas S, Lerner U H.
    Cytokine 2005:30(2):56-63.
    [Links: PMID: 15804596 | DOI länk][Source: PubMed®]
    Web of Science® citations 33
  115. The cytolethal distending toxin of Haemophilus ducreyi aggravates dermal lesions in a rabbit model of chancroid.
    Wising Catharina, Mölne Lena, Jonsson Ing-Marie, Ahlman Karin, Lagergård Teresa.
    Microbes Infect. 2005:7(5):867-74.
    [Links: PMID: 15876546 | DOI länk][Source: PubMed®]
    Web of Science® citations 8
  116. Antibodies against Haemophilus influenzae type b capsular polysaccharide and tetanus toxoid before and after a booster dose of the carrier protein nine years after primary vaccination with a protein conjugate vaccine.
    Claesson Bo A, Trollfors Birger, Lagergård Teresa, Knutsson Nina, Schneerson Rachel, Robbins John B.
    Pediatr Infect Dis J. 2005:24(5):463-4.
    [Links: PMID: 15876951][Source: PubMed®]
    Web of Science® citations 6
  117. Multilocus sequence typing of Swedish invasive group B streptococcus isolates indicates a neonatally associated genetic lineage and capsule switching.
    Luan Shi-Lu, Granlund Margareta, Sellin Mats, Lagergård Teresa, Spratt Brian G, Norgren Mari.
    J Clin Microbiol. 2005:43(8):3727-33.
    [Links: PMID: 16081902 | DOI länk][Source: PubMed®]
    Web of Science® citations 62
  118. Diphtheria, tetanus and pertussis antibodies in 10-year-old children before and after a booster dose of three toxoids: implications for the timing of a booster dose.
    Trollfors Birger, Knutsson Nina, Taranger John, Mark Anders, Bergfors Elisabet, Sundh Valter, Lagergård Teresa.
    Eur J Pediatr. 2006:165(1):14-8.
    [Links: PMID: 16249929 | DOI länk][Source: PubMed®]
    Web of Science® citations 3
  119. Molecular characterization of Haemophilus ducreyi isolates from different geographical locations.
    Mbwana J, Bölin I, Lyamuya E, Mhalu F, Lagergård T.
    J Clin Microbiol. 2006:44(1):132-7.
    [Links: PMID: 16390960 | DOI länk][Source: PubMed®]
    Web of Science® citations 2
  120. Mature glycoprotein g presents high performance in diagnosing herpes simplex virus type 2 infection in sera of different tanzanian cohorts.
    Görander Staffan, Mbwana Judica, Lyamuya Eligius, Lagergård Teresa, Liljeqvist Jan-Ake.
    Clin Vaccine Immunol. 2006:13(6):633-9.
    [Links: PMID: 16760320 | DOI länk][Source: PubMed®]
    Web of Science® citations 4
  121. Binding of Haemophilus ducreyi to carbohydrate receptors is mediated by the 58.5-kDa GroEL heat shock protein.
    Pantzar Martina, Teneberg Susann, Lagergård Teresa.
    Microbes Infect. 2006:8(9-10):2452-8.
    [Links: PMID: 16880000 | DOI länk][Source: PubMed®]
    Web of Science® citations 2
  122. Prevalence of serum antibodies to human papilloma virus in patients with genital ulcer disease in an urban population of Tanzania.
    Mbwana J, Viscidi R, Lyamuya E, Mhalu F, Chalamilla G, Liljeqvist J-A, Lagergård T.
    Sex Transm Infect 2007:83(1):64-5.
    [Links: PMID: 16807287 | DOI länk][Source: PubMed®]
    Web of Science® citations 1
  123. Formaldehyde treatment increases the immunogenicity and decreases the toxicity of Haemophilus ducreyi cytolethal distending toxin.
    Lagergård Teresa, Lundqvist Annika, Wising Catharina, Gabrielsson Vivianne, Ahlman Karin.
    Vaccine 2007:25(18):3606-14.
    [Links: PMID: 17289219 | DOI länk][Source: PubMed®]
    Web of Science® citations 5
  124. [Streptococcus group B--association with Aerobic vaginitis and ability to human cell lines activation].
    Romanik Ma, Kafel Joanna, Lagergård Teresa, Martirosian Gayane.
    Med Dosw Mikrobiol 2007:59(2):85-91.
    [Links: PMID: 17929406][Source: PubMed®]
  125. Seroprevalences of herpes simplex virus type 2, five oncogenic human papillomaviruses, and Chlamydia trachomatis in Katowice, Poland.
    Görander Staffan, Lagergård Teresa, Romanik Malgorzata, Viscidi Raphael P, Martirosian Gayane, Liljeqvist Jan-Ake.
    Clin Vaccine Immunol. 2008:15(4):675-80.
    [Links: PMID: 18287578 | DOI länk][Source: PubMed®]
    Web of Science® citations 4
  126. Cytolethal distending toxin upregulates RANKL expression in Jurkat T-cells.
    Belibasakis Georgios N, Brage Monica, Lagergård Teresa, Johansson Anders.
    APMIS 2008:116(6):499-506.
    [Links: PMID: 18754324][Source: PubMed®]
    Web of Science® citations 4
  127. Immunogenic and adjuvant properties of Haemophilus ducreyi lipooligosaccharides.
    Lundqvist Annika, Kubler-Kielb Joanna, Teneberg Susann, Ahlman Karin, Lagergård Teresa.
    Microbes Infect. 2009:11(3):352-60.
    [Links: PMID: 19397884 | DOI länk][Source: PubMed®]
  128. Toxic activity of the CdtB component of Haemophilus ducreyi cytolethal distending toxin expressed from an adenovirus 5 vector.
    Wising Catharina, Magnusson Maria, Ahlman Karin, Lindholm Leif, Lagergård Teresa.
    APMIS 2010:118(2):143-9.
    [Links: PMID: 20132178 | DOI länk][Source: PubMed®]
    Web of Science® citations 0
  129. Distribution of Chlamydia trachomatis ompA genovars and the new variant of C. trachomatis in the Göteborg area, Sweden.
    Lagergård T, Hadad R, Tunbäck P, Lindholm L, Löwhagen G-B, Unemo M.
    Eur J Clin Microbiol Infect Dis. 2010:29(5):609-11.
    [Links: PMID: 20195670 | DOI länk][Source: PubMed®]
  130. Detoxified Haemophilus ducreyi cytolethal distending toxin and induction of toxin specific antibodies in the genital tract.
    Lundqvist Annika, Fernandez-Rodrigez Julia, Ahlman Karin, Lagergård Teresa.
    Vaccine 2010
    [Links: PMID: 20609397 | DOI länk][Source: PubMed®]
    Web of Science® citations 1

Book Chapter (4)

  1. Epiglottitis and pseudocroup.
    Branefors P P, Nylén O O, Lagergård T Teresa.
    Infectious Diseases and Medical Microbiology. Philadelphia: Saunders; 1986, ISBN 0721612067, 97807216.
    [Source: User]
  2. Haemophilus influenzae antibodies.
    Dahlberg-Lagergård Teresa.
    Methods of enzymatic analysis. Weinheim, Tyskland: VCH; 1986, pp 160-173. ISBN 3527260528, 97835272.
    [Source: User]
  3. A tale of two toxins.
    Robbins J.B, Szu S.C, Schneerson R, Trollfors B, Lagergård Teresa. A, Taranger J.
    Vaccines 94: modern approaches to new vaccines including prevention of AIDS. Cold Spring Harbor,USA: Cold Spring Harbor Laboratory Press; 1994, pp 99-111.
    [Source: User]
  4. Haemophilus ducreyi.
    Lagergård Teresa.
    Molecular Medical Microbiology. Academic Press; 2002, pp 1809-1824. ISBN 0126775303, 97801267.
    [Source: User]

Article - Other scientific (3)

  1. Low milk IgA antibody to Haemophilus influenzae colonising nasopharynx of infants.
    von Rosen I A, Aniansson G, Svanborg Eden C, Lagergard T.
    Lancet 1990:335(8688):548.
    [Links: PMID: 1968563][Source: PubMed®]
    Web of Science® citations 2
  2. Haemophilus ducreyi och chankroid.
    Lagergård Teresa.
    Tropik Nytt 1994:15
    [Source: User]
  3. Parapertussis infection followed by pertussis infection.
    Taranger J, Trollfors B, Lagergård T, Zackrisson G.
    Lancet 1994:344(8938):1703.
    [Links: PMID: 7996979][Source: PubMed®]
    Web of Science® citations 21

Accepterade men ännu ej publicerade publikationer

Lärobok i medicinsk mikrobiologi. kapitel: Pasteurellaceae and Bordetella, Francisella, Brucella. Studetlitteratur AB, 2010. (in press).

Manuskript ännu ej accepterade för publikation

Joanna Kubler-Kielb, Evgeny Vinogradov, Ariel Ginzberg, Teresa Lagergard, Jerry King, John B. Robbins, Rachel Schneerson. Use of Bordetella bronchiseptica O-specific polysaccharide deficient mutants to produce saccharide/protein conjugates inducing bactericidal antibodies against B. pertussis; a potential addition to the pertussis vaccine. (in manuscript).
information Nedan visas publikationer tillfälligt inlagda som text innan de konverteras till publikationsdatabasen.

Övriga publikationer

Wising Catharina, Maria Magnusson, Karin Ahlman, Leif Lindholm and Lagergård T. Toxic activity of the CdtB component of Haemophilus ducreyi cytolethal distending toxin expressed from an Adenovirus 5 vector. APMIS. 2010 Feb;118(2):143-9.
Arbetsgivare Anställningsgrad BörjadeSlutade
Övrigt Show info
Ortopedic Hospital in Otwock/Warszawa

 100% 1970 1973
Övrigt - Övrigt Show info
Statligt - Universitet - Göteborgs universitet - Sahlgrenska akademin - Institutionen för medicinsk mikrobiologi och immunologi

 100% 1974 1990
Övrigt Show info
USA Bethesda, NIH, senare 2007 och nu sabatical i USA.

 1987 1988
Statligt - Universitet - Göteborgs universitet - Sahlgrenska akademin - Institutionen för medicinsk mikrobiologi och immunologi [1991 - 2005]
 100% 1991 2005
Statligt - Universitet - Göteborgs universitet - Sahlgrenska akademin - Institutionen för biomedicin, avdelningen för mikrobiologi och immunologi [2006 - ]
 100% 2006

Pedagogisk utbildning
Genomgånget lärarprov 1985 (docentföreläsning).
Förnyad pedagogisk utbildning genom deltagande i Högskolepedagogisk, introduktionskurs för lärare vid Göteborgs Universitet, 5 dagars utbildning , VT 1995.
Pedagogisk fortbildning kurs vid medicinska och odontologiska fakulteterna, Göteborgs Universitet, VT 1997.

Undervisning
Grundutbildning. Sedan 1976 har jag deltagit i undervisningen i medicinsk mikrobiologi för medicine och odontologi studerande vid härvarande institution.
Undervisningen omfattade 3 kurser per termin: i cellbiologi och medicinsk mikrobiologi för medicine studerande och medicinsk mikrobiologi för odontologi studerande. Jag har varit föreläsare (ca 10-15 föreläsningar per kurs), laborationsledare, seminarieledare och kursledare.
Från VT 1997 undervisning i medicinsk mikrobiologi omfattade både medicine och odontologie studenter. Från den tiden har jag varit mest involverad i föreläsningar (5 föreläsningar per kurs), seminarie verksamhet (16 timmar/kurs), omorganiserning av kursen, samordning och integrering av mikrobiologi och immunologi ämnena.
Vidare, har jag varit ansvarig för kursen för Göteborgsforskarskola (Strategiska fonder) inom programmet Infektion och Vaccinologi.

Forskarutbildning. Jag har varit organisatör och kursledare för en forskarutbildningkurs " Bacterial polysaccharides in infection, immunity and vaccine development" och det andra “Infectious diseaes in developing countries: microbiology, immunology, prevention and research problems”, vårtermin 1999. Vidare, har jag varit föreläsare vid olika forskarutbildningskurser organiserade av olika institutioner inom ämnet mikrobiologi, immunologi och vacciner.

Jag har varit handledare för:
b) Co-supervisor for postdoctoral thesis:
Oscar Porras M.D. PhD, defended 1985.
Bo Claesson, M.D. PhD, defended 1988.
Jerker Isacsson M.D. PhD, defended 1996.
Charlotta Bergquist. Ph.D, defended 1997.
Stefan Berg, M.D. Ph.D., defended 2000.
Xuzhuang Shen, MD. PhD., defended 2000
Full-supervisor for postdoctoral thesis:
Gunilla Zackrisson, M.D. Ph.D, defended 1989.
Maria Purvèn , Ph.D., defended 1996.
Anders Frisk. Ph.D. defended 1998.
Liselotte Svensson, Ph.D, defended 2002.
Supervisor for ongoing PhD students:
Catarina Johansson Fil. Kand.
Annika Lundgren Fil Kand.
Judica Mbwana, MSc.

Vidare, har jag varit handledare vid projekt arbete för 4 studenter (20 p) och två medicinare , termin 7 för arbete ”Studies of genital ulceration disease in patients attending the STD clinic in Durban , South Africa, 1998.

Jag har varit inviterad föreläsare vid olika Universiteten och Instituten eg. Dar es Salaam, Muhimbili Medical center, Tanzania; Beijings Children Hospital, Beijing, China; NIH, NICHD, Bethesda, USA; Warsaw Medical Academy, Warsaw, Poland; etc.samt deltagare i många kongresser och internationella symposier.

Detta har inneburit att jag har erfarenhet inom olika undervisningsformer som föreläsningar, seminarier, gruppundervisning, laborationer, projektorganiserad undervisning, under ca 23 år.

Läromedel
Utarbetande av läroboksavsnitt, kurskompendier, studiematerial och forskning information.
Jag har också deltagit som författare i 3 böcke: A.J. Brande "Infectious diseases and medical microbiology" med kapitlet "Epiglottitis and pseudocroup"
"Haemophilus influenzae antibodies" i en metodologisk bok "Methods of enzymatic analysis”
Haemophilus ducreyi in Molecular Medical Microbiology, ed Sussman. 2002.
Lärobok I medicinsk mikrobiologi, två kapitel, under arbetet.

Scientific meetings and organisations
a) I have actively participated in about 50 international symposia and congresses (in Europe, North America, Israel, Africa, Asia, Australia) and in invited lectures at e.g. University of Dar es Salaam, Tanzania; NICHD, NIH, Bethesda, USA; New Orleans, USA, Satellite symposium on chancroid; Beijing Children’s Hospital, Beijing, China, Warsaw Medical Academy, Poland, University of Natal, Durban, SA.

b) Member of professional organisations:
Swedish Medical Society from 1982 - present
American Society for Microbiology from 1987 – present

Patents
U.S. Provisional Patent Application No. E-183-2005/0-US-01 filled July 21, 2006. Methods for Conjugation of Oligosaccharides or Polysaccharides to Protein Carriers Through Oxime Linkages Via 3-Deoxy-D-Manno-Octulsonic Acid. Together with J Kubler-Kielb, V Pozsgt, G Ben-Menachem, R Schneerson, NIH, NICHD.

Member of The Royal Society of Arts and Scienses in Göteborg, (Kungliga Vetenskaps-och Vitterhets-Samhället i Göteborg) from 2002- present.

c ) Member of organising committee of Scandinavian Society for Immunology, Annual meeting 1995, Göteborg.
e) Member of the examination collegium for post-graduate students at the Medical Faculty, Göteborg University.
d) Member of Institutional Board at the Department of Medical Microbiology and Immunology.
e) Served as referee for the following journals:
Microbial Pathogenesis, Microbiology, AMPIS, The Journal of Immunology, European Journal of Clinical Microbiology and Infectious diseases, Infection and Immunity, Molecular Microbiology.
f) member of Eric Fernströms awardcomitee at Sahlgrenska Academy ( 2003-2005).
Present laboratory members
Teresa Lagergård, Ph.D. principal investigator (Professor)
Martina Pantzar, (scientist)
Catarina Johansson, Fil. kand. student, Annika Lundquist Fil. Kand, Judica Mbwana, MSc, Ph. D. students
Karin Ahlman and Vivianne Sundeus, Lab. Technicians,

Collaboration.
Involved in numerous international collaborative projects.
In developing countries: Muhimbili Medical Centre, Dar es Salaam, Mbeya Hospital, Tanzania; Department of Medical Microbiology, Faculty of Medicine, University of Natal, Durban, South Africa; Beijing Children hospital, Beijing, China.
In developed countries: NICHD, NIH, Bethesda, MD, USA; Department of Microbiology, The University of Texas, South-western Medical Center, Dallas, Texas, USA; Imperial College of Science, Technology and Medicine, at St. Mary’s. Department of Medical Microbiology, London, UK; Institute of Tropical Medicine, Department of Microbiology, Antwerp, Belgium; Medical Academy of Warsaw, Department of Microbiology, Warsaw, Poland; MTC, Karolinska Institute, Stockholm, Sweden. etc.

Informationen är tillförlitlig | uppdaterad: 2011-01-19 av Teresa Lagergård |
Personkort för Teresa Lagergård, från FoU-enheten för Primärvård och Folktandvård Södra Älvsborg
http://www.fou.nu/is/foualvsborg/user/html/3131